CE: Glucagon as an Underutilized Approach: Advancing the Management of Severe Hypoglycemia

Pharmacy Times, February 2020, Volume 87, Issue 2

This activity is supported by an independent educational grant from Xeris Pharmaceuticals, Inc.

This activity is supported by an independent educational grant from Xeris Pharmaceuticals, Inc.

FACULTY

Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, BCACP, Endocrine Clinical Pharmacy Specialist at the Cleveland Clinic Endocrinology & Metabolism Institute Diabetes Center in Cleveland, Ohio.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

  • Identify the risk factors, signs and symptoms, and classifications of hypoglycemia
  • Examine the management options for hypoglycemia and common barriers that affect patient outcomes
  • Explore the safety, efficacy, and clinical benefits of new agents used for severe hypoglycemia
  • Optimize the role of the pharmacist in educating patients and caregivers on recommended treatment strategies for severe hypoglycemia to improve patient outcomes

TARGET AUDIENCE: Community pharmacists and long-term care pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: February 14, 2020

EXPIRATION DATE: February 14, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.5 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.